Innovation Theater

Brunch Innovation Theater (Non-Accredited): Impact, Assessment, and Treatment of Tardive Dyskinesia: A Focus on Patient-Reported Outcomes With a VMAT2 Inhibitor

60 min
Saturday, January 16, 2027
10:10 AM - 11:10 AM
Brunch will be served. Seating is limited and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):

Scott Weiner, MD; Founder and Chief Medical Officer; Prisma Wellness; Renton, WA

This presentation is sponsored by Neurocrine Biosciences, Inc.
share
Back to top